logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 2
  • 1
    Comran, Mohammad Tahir
    Born in October 1976
    Individual (8 offsprings)
    Officer
    2018-02-21 ~ now
    OF - Director → CIF 0
    Mr Mohammad Tahir Comran
    Born in October 1976
    Individual (8 offsprings)
    Person with significant control
    2018-02-21 ~ 2022-12-14
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Q2 GROUP INTERNATIONAL LIMITED
    13999727
    51, Hughenden Road, High Wycombe, England
    Active Corporate (1 parent, 3 offsprings)
    Person with significant control
    2022-12-14 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

Q2 PHARMA LIMITED

Period: 2018-02-21 ~ now
Company number: 11218653 10004961
Registered name
Q2 PHARMA LIMITED - now 10004961
Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Intangible Assets
305,099 GBP2025-02-28
343,236 GBP2024-02-28
Property, Plant & Equipment
296,386 GBP2025-02-28
136,695 GBP2024-02-28
Fixed Assets
601,485 GBP2025-02-28
479,931 GBP2024-02-28
Debtors
635,143 GBP2025-02-28
477,182 GBP2024-02-28
Cash at bank and in hand
417,466 GBP2025-02-28
234,058 GBP2024-02-28
Current Assets
1,167,859 GBP2025-02-28
846,230 GBP2024-02-28
Net Current Assets/Liabilities
67,257 GBP2025-02-28
52,403 GBP2024-02-28
Total Assets Less Current Liabilities
668,742 GBP2025-02-28
532,334 GBP2024-02-28
Equity
Called up share capital
200 GBP2025-02-28
200 GBP2024-02-28
Retained earnings (accumulated losses)
668,542 GBP2025-02-28
532,134 GBP2024-02-28
Equity
668,742 GBP2025-02-28
532,334 GBP2024-02-28
Average Number of Employees
182024-02-29 ~ 2025-02-28
132023-03-01 ~ 2024-02-28
Intangible Assets - Gross Cost
Net goodwill
381,373 GBP2024-02-28
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
76,274 GBP2025-02-28
38,137 GBP2024-02-28
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
38,137 GBP2024-02-29 ~ 2025-02-28
Intangible Assets
Net goodwill
305,099 GBP2025-02-28
343,236 GBP2024-02-28
Property, Plant & Equipment - Gross Cost
Owned/Freehold, Land and buildings
99,650 GBP2024-02-28
Plant and equipment
120,317 GBP2025-02-28
80,940 GBP2024-02-28
Property, Plant & Equipment - Gross Cost
383,156 GBP2025-02-28
180,590 GBP2024-02-28
Land and buildings, Owned/Freehold
262,839 GBP2025-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
44,735 GBP2025-02-28
28,144 GBP2024-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
86,770 GBP2025-02-28
43,895 GBP2024-02-28
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
16,591 GBP2024-02-29 ~ 2025-02-28
Property, Plant & Equipment - Increase From Depreciation Charge for Year
42,875 GBP2024-02-29 ~ 2025-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings, Owned/Freehold
42,035 GBP2025-02-28
Property, Plant & Equipment
Land and buildings, Owned/Freehold
220,804 GBP2025-02-28
Plant and equipment
75,582 GBP2025-02-28
52,796 GBP2024-02-28
Owned/Freehold, Land and buildings
83,899 GBP2024-02-28
Trade Debtors/Trade Receivables
Current
290,904 GBP2025-02-28
180,560 GBP2024-02-28
Other Debtors
Current, Amounts falling due within one year
344,239 GBP2025-02-28
296,622 GBP2024-02-28
Debtors
Current, Amounts falling due within one year
635,143 GBP2025-02-28
477,182 GBP2024-02-28
Trade Creditors/Trade Payables
Current
535,427 GBP2025-02-28
465,174 GBP2024-02-28
Corporation Tax Payable
Current
57,977 GBP2025-02-28
24,553 GBP2024-02-28
Other Taxation & Social Security Payable
Current
11,518 GBP2025-02-28
4,462 GBP2024-02-28
Other Creditors
Current
495,680 GBP2025-02-28
299,638 GBP2024-02-28

Related profiles found in government register
  • Q2 PHARMA LIMITED
    Info
    Registered number 11218653
    51 Hughenden Road, High Wycombe HP13 5HS
    PRIVATE LIMITED COMPANY incorporated on 2018-02-21 (8 years 4 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-02-27
    CIF 0
  • Q2 PHARMA LIMITED
    S
    Registered number 11218653
    51, Hughenden Road, High Wycombe, England, HP13 5HS
    Private Company Limited By Shares in Uk Register Of Companies, United Kingdom
    CIF 1
child relation
Offspring entities and appointments 1
  • 1
    HQ PHARMA 2 LIMITED
    16643296
    51 Hughenden Road, High Wycombe, England
    Active Corporate (4 parents)
    Person with significant control
    2025-08-11 ~ now
    CIF 1 - Ownership of shares – More than 50% but less than 75% OE
    CIF 1 - Right to appoint or remove directors OE
    CIF 1 - Ownership of voting rights - More than 50% but less than 75% OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.